- Home
- AMBC vs EYPT Comparison
AMBC vs EYPT Comparison
Compare AMBC & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- EYPT
- Stock Information
- Founded
- AMBC 1971
- EYPT 1987
- Country
- AMBC United States
- EYPT United States
- Employees
- AMBC N/A
- EYPT N/A
- Industry
- AMBC Property-Casualty Insurers
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- AMBC Finance
- EYPT Industrials
- Exchange
- AMBC Nasdaq
- EYPT Nasdaq
- Market Cap
- AMBC 411.3M
- EYPT 579.4M
- IPO Year
- AMBC 1991
- EYPT 2005
- Fundamental
- Price
- AMBC $7.62
- EYPT $10.38
- Analyst Decision
- AMBC Strong Buy
- EYPT Strong Buy
- Analyst Count
- AMBC 1
- EYPT 8
- Target Price
- AMBC $15.00
- EYPT $24.75
- AVG Volume (30 Days)
- AMBC 953.5K
- EYPT 779.7K
- Earning Date
- AMBC 08-04-2025
- EYPT 08-06-2025
- Dividend Yield
- AMBC N/A
- EYPT N/A
- EPS Growth
- AMBC N/A
- EYPT N/A
- EPS
- AMBC N/A
- EYPT N/A
- Revenue
- AMBC $253,912,000.00
- EYPT $56,042,000.00
- Revenue This Year
- AMBC N/A
- EYPT N/A
- Revenue Next Year
- AMBC $17.41
- EYPT N/A
- P/E Ratio
- AMBC N/A
- EYPT N/A
- Revenue Growth
- AMBC 125.08
- EYPT 12.04
- 52 Week Low
- AMBC $5.99
- EYPT $3.91
- 52 Week High
- AMBC $13.64
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- AMBC 60.91
- EYPT 66.76
- Support Level
- AMBC $6.97
- EYPT $9.45
- Resistance Level
- AMBC $8.07
- EYPT $10.20
- Average True Range (ATR)
- AMBC 0.29
- EYPT 0.75
- MACD
- AMBC 0.11
- EYPT -0.02
- Stochastic Oscillator
- AMBC 71.88
- EYPT 86.04
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.